Medical devices, healthcare technology and the business of care
PMA approval · P220024

LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device

Advanced Medical Solutions Limited · Decision date Jun 2, 2023

FDA DECISIONP220024

What did the FDA approve?

FDA records P220024 as an original PMA application. The recorded decision is approval, dated Jun 2, 2023.

FDA approval order statement

Approval for The LIQUIFIX FIX8 Hernia Mesh Fixation device is intended for use in laparoscopic surgical repair of groin (inguinal and femoral) hernias, achieved through the fixation of prosthetic polypropylene or polyester mesh to the abdominal wall and the approximation of the peritoneum.The LIQUIFIX Precision Open Hernia Mesh Fixation device is intended for use in open surgical repair of groin (inguinal and femoral) hernias, achieved through the fixation of prosthetic polypropylene or polyester mesh to the abdominal wall.
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Jun 2, 2023

FDA source record

Regulatory record facts

Identifier
P220024
Regulatory pathway
Premarket approval application
Product code
PLJ
Decision code
APPR
Decision date
Jun 2, 2023
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tissue adhesive internal use.

Product code
PLJ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P220024 received

    Application receipt date recorded by FDA.

  2. P220024 · FDA decision

    APPR

  3. P220024/S007 · Related supplement

    LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation Device

Timeline entries are records held by MedtechLedger for P220024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220024

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Advanced Medical Solutions Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Western Wood Way, Langage Science Park, Plymouth, PL7 5BG

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records